Table 3.
Patient ID | Gender | Age |
Liver function tests (normal range) |
HEV |
Travel history | Initial/ | Outcome | ||||||||
ALT | Billirubin | ALP | Gamma GTP | Albumin | PT | IgG | IgM | RNA | Genotype | retrospective | |||||
(10-50 IU/mL) | (< 17 μmol/L) | (40-125 IU/L) | (5-35 IU/mL) | (30-50 g/L) | (8-12 s) | (IU/mL) | (IU/mL) | diagnosis | |||||||
1 | Female | 58 | 3648 | 92 | 540 | 480 | 35 | 16 | 48.4 | + | 6.4 × 104 | 3 | Spain, Cornwall | DILI/hepatitis E | Survived |
2 | Female | 67 | 98 | 516 | 256 | Icteric1 | 19 | 14 | 36.49 | + | 1.4 × 103 | 3 | Spain | Alcohol, T2Diabetes, obesity, CLD/hepatitis E | Died |
3 | Male | 27 | 5288 | 140 | 186 | 368 | 27 | 35 | 24.7 | + | - | - | London | POD/hepatitis E | Survived |
4 | Male | 27 | 4044 | 269 | 253 | Icteric1 | 38 | 25 | 42.05 | + | 1.9 × 104 | 1 | India | Hepatitis E | Survived |
GTP could not be calculated due to high serum bilirubin levels. Values obtained from serum samples taken on admission to SLTU. ALT: Alanine aminotransferase; ALP: Alkaline phosphatase; GTP: Glutamyl transpeptidase; PT: Prothrombin time; HEV: Hepatitis E virus; Ig: Immunoglobulin; RNA: Ribonucleic acid; DILI: Drug induced liver injury; CLD: Chronic liver disease; POD: Paracetamol overdose.